Akari Therapeutics, Plc
(NASDAQ) AKTX
Akari Therapeutics, Plc Financials at a Glance
Market Cap
$4.24M
Revenue (TTM)
$0.00
Net Income (TTM)
$15.73M
EPS (TTM)
$-0.48
P/E Ratio
-0.02
Dividend
$0.00
Beta (Volatility)
0.47 (Low)
Dividend
$0.00
Beta (Volatility)
0.47 (Low)
Price
$0.13
Volume
808
Open
$0.14
Price
$0.13
Volume
808
Open
$0.14
Previous Close
$0.13
Daily Range
$0.13 - $0.14
52-Week Range
$0.13 - $1.58
Dividend
$0.00
Beta (Volatility)
0.47 (Low)
Price
$0.13
Volume
808
Open
$0.14
Previous Close
$0.13
Daily Range
$0.13 - $0.14
52-Week Range
$0.13 - $1.58
AKTX News
AKTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Akari Therapeutics, Plc
Industry
Biotechnology
Sector
Health CareEmployees
9
CEO
Abizer Gaslightwala, MBA
Website
www.akaritx.comHeadquarters
London, W1G 9RT, GB
AKTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-197%
Return on Capital
-44%
Return on Assets
-35%
Earnings Yield
-50.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.24M
Shares Outstanding
32.61M
Volume
808
Short Interest
0.00%
Avg. Volume
453.11K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$21.64M
EBITDA
$19.53M
Operating Cash Flow
$12.55M
Capital Expenditure
$0.00
Free Cash Flow
$12.55M
Cash & ST Invst.
$2.60M
Total Debt
$3.26M
Akari Therapeutics, Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$4.24M
N/A
Market Cap/Employee
$530.40K
N/A
Employees
8
N/A
Net Income
$6.36M
-119.7%
EBITDA
$7.32M
-159.1%
Quarterly Fundamentals
Net Cash
$367.00K
-70.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$2.12M
+111.7%
Return on Assets
-34.67%
N/A
Return on Invested Capital
-44.11%
N/A
Free Cash Flow
$2.10M
-41.1%
Operating Cash Flow
$2.10M
-41.1%